Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1150
-0.0050 (-4.17%)
At close: Mar 20, 2026
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 21.55 million as of March 20, 2026. Its market cap has increased by 5.88% in one year.
Market Cap
21.55M
Enterprise Value
23.83M
Revenue
175.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 21.55M, an increase of 215.72%. That is a compound annual growth rate of 6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 21.55M | -8.53% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cannabix Technologies | 89.41M |
| Theralase Technologies | 79.42M |
| Perimeter Medical Imaging AI | 61.35M |
| Conavi Medical | 38.81M |
| Cheelcare | 34.39M |
| Aurora Spine | 21.30M |
| MedX Health | 18.04M |
| Frequency Exchange | 15.68M |